Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for biopsy-confirmed chronic allograft nephropathy in kidney transplant recipients
2005-000936-26Phase 4Active
- Sponsor
- Wyeth Farma, S.A.
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in Chronic Allograft Kidney Disease (CKaD), sponsored by Wyeth Farma, S.A. Started Dec 2005; status: active.
02
Drugs
sirolimus
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on 2005-000936-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000936-26.